Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Butylphthalide

Butylphthalide

pharmaceutical raw materials
Butylphthalide structure

Butylphthalide 

structure
  • CAS No:

    6066-49-5

  • Formula:

    C12H14O2

  • Chemical Name:

    Butylphthalide

  • Synonyms:

    1(3H)-Isobenzofuranone,3-butyl-;Phthalide,3-butyl-;3-Butyl-1(3H)-isobenzofuranone;Butylphthalide;3-n-Butylphthalide;3-Butylphthalide;(±)-3-Butylphthalide;3-Butyl-1,3-dihydro-2-benzofuran-1-one;3-Butyl-3H-2-benzofuran-1-one;L-3-N-Butylphthalide;L-NBP;93133-67-6

  • Categories:

    Cosmetic Ingredient  >  Perfuming

Description

Butylphthalide(3-n-Butylphthalide) is an anti-cerebral-ischemia drug; first isolated from the seeds of celery, showed efficacy in animal models of stroke.IC50 value:Target:3-n-butylphthalide alleviates oxidative stress caused by chronic cerebral ischemia, improves cholinergic function, and inhibits amyloid beta accumulation, thereby improving cerebral neuronal injury and cognitive deficits [2]. Intragastric NBP administration to 4-month-old SAMP8 mice for 2 months significantly improved


colourless, oily liquid; warm-spicy herbaceous aroma


Butylphthalide is a member of benzofurans.|Butylphthalide has been used in trials studying the prevention of Restenosis.

Butylphthalide Basic Attributes

190.24

190.24

228-000-8

2932209090

Characteristics

26.3

2.8

colourless, oily liquid; warm-spicy herbaceous aroma

1.1±0.1 g/cm3

138-139 °C @ Press: 6 Torr

128.3±22.2 °C

1.525

Slightly soluble in water; soluble in oil

Oral-rat LD50: 2450 mg/kg

Thermal decomposition emits spicy and irritating smoke

Safety Information

Warehouse ventilated, low temperature and dry

P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501

H315

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 125 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

moderately toxic

Drug Information

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)|Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)

(S)-(-)-3-butylphthalide

Butylphthalide Use and Manufacturing

1(3H)-Isobenzofuranone, 3-butyl-: ACTIVE

Food additives -> Flavoring Agents|Flavoring Agents -> JECFA Flavorings Index

Flavoring Agents

Computed Properties

Molecular Weight:190.24
XLogP3:2.8
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:3
Exact Mass:190.099379685
Monoisotopic Mass:190.099379685
Topological Polar Surface Area:26.3
Heavy Atom Count:14
Complexity:212
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Butylphthalide is a synthetic racemic n-butylphthalide, which has the same structure as the natural L-apigenin. Clinical research results show that butylphthalide can improve the damage of central nervous system function in patients with acute ischemic stroke and promote the improvement of patients' neurological deficits. Animal pharmacodynamic studies have shown that butylphthalide can block multiple pathological links of brain damage caused by ischemic stroke, has a strong anti-cerebral ischemia effect, can significantly reduce the infarct area of local cerebral ischemia in rats, reduce brain edema, improve brain energy metabolism and microcirculation and blood flow in ischemic brain areas, inhibit nerve cell apoptosis, and has anti-cerebral thrombosis and anti-platelet aggregation effects. Butylphthalide may exert the above-mentioned pharmacodynamic effects by reducing arachidonic acid content, increasing the levels of NO and PGI2 in cerebral vascular endothelial cells, inhibiting glutamate release, reducing intracellular calcium concentration, inhibiting free radicals and increasing antioxidant enzyme activity.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Zhejiang Liaoyuan Pharmaceutical Co., Ltd.

    China China
    Active
  • Jilin Qijian Bio-Pharmaceutical Co., Ltd.

    China China
    Active
  • Xiangbei Welman Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Butylphthalide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.